Login / Signup

Kaempferol suppresses acetaminophen-induced liver damage by upregulation/activation of SIRT1.

Mona Nasser BinMowynaNora Abdullah AlFaris
Published in: Pharmaceutical biology (2021)
This study encourages the use of kaempferol in further clinical trials to treat APAP-induced hepatotoxicity.
Keyphrases
  • drug induced
  • clinical trial
  • high glucose
  • diabetic rats
  • liver injury
  • oxidative stress
  • signaling pathway
  • poor prognosis
  • stress induced
  • double blind
  • phase iii